Furthermore, peripheral CD8+ T cells from nine CHB and eleven hepatitis B-related HCC patients were co-cultured with HepG2.215 cells in the presence of HBV core 18-27 peptide for maintenance of HBV-specific T cell response. The gene discussed is CD8A; the disease is hepatocellular carcinoma.